Bill

Bill > S03105


NY S03105

NY S03105
Provides for reciprocity agreements with other states for medical cannabis programs; directs the cannabis control board to promulgate regulations for the approval of pre-roll products in the medical cannabis program.


summary

Introduced
01/23/2025
In Committee
01/07/2026
Crossed Over
06/11/2025
Passed
Dead

Introduced Session

2025-2026 General Assembly

Bill Summary

AN ACT to amend the cannabis law, in relation to certain medical cannabis reforms

AI Summary

This bill introduces two key changes to New York's cannabis law. First, it establishes a reciprocity program for out-of-state medical cannabis patients, allowing individuals who are legally authorized to use medical cannabis in their home state to use cannabis in New York, provided they follow the state's legal limits on possession and production. To do this, non-resident patients must present legitimate documentation of their medical cannabis authorization and comply with New York's medical cannabis regulations. The bill directs the cannabis control board to develop specific regulations for implementing this reciprocity program and potentially create reciprocity agreements with other states that have medical cannabis programs. Second, the bill requires the cannabis control board to create regulations for approving pre-roll (pre-rolled cannabis) products specifically within the medical cannabis program. The legislation is designed to provide more flexibility for medical cannabis patients who are not New York residents and to expand product options for the state's medical cannabis program.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (2)

Last Action

ADVANCED TO THIRD READING (on 03/19/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...